Abstract
ABSTRACT: Inhibition of IGF-I action by circulating IGF-I receptor autoantibodies is a potential mechanism of IGF-I resistance in growing children. To define the prevalence of IGF-I receptor antibodies in short-statured children, we have examined serum and plasma samples from a well-characterized group of 34 short, prepubertal, growth hormone-sufficient children and three growth hormonedeficient children. IGF-I receptor purified from human placental membranes was radioiodinated by the solid phase radioiodination method. Serum from a patient with severe insulin resistance immunoprecipitated 28.9–44.7% of the 125I-labeled IGF-I receptor. The ranges (mean ± 3 SD) of 125I-labeled IGF-I receptor Immunoprecipitated by 1:10 diluted and by undiluted nonimmune human serum were 1.99 ± 0.63% and 4.42 ± 1.32%, respectively. Immunoprecipitation of the 125I-labeled IGF-I receptor by eight samples from six children was > 3 SD above the mean when assayed at a 1:10 dilution. Nevertheless, when assayed undiluted, only one of these samples immunoprecipitated slightly more 125I-labeled IGF-I receptor than non-immune serum. We conclude from these data that immunoprecipitating autoantibodies to the IGF-I receptor are not commonly present in short-statured children.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thompson, K., Dempsher, D., Bier, D. et al. Low Prevalence of Autoantibodies to the Insulin-like Growth Factor I Receptor in Children with Short Stature. Pediatr Res 32, 455–459 (1992). https://doi.org/10.1203/00006450-199210000-00016
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199210000-00016